HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC decreased its stake in HealthEquity, Inc. (NASDAQ:HQY) by 8.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 951,235 shares of the company’s stock after selling 86,545 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in HealthEquity were worth $92,079,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of HQY. Louisiana State Employees Retirement System boosted its holdings in HealthEquity by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock worth $2,322,000 after buying an additional 100 shares during the last quarter. Raymond James Trust N.A. raised its holdings in shares of HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after acquiring an additional 132 shares during the last quarter. UMB Bank n.a. lifted its position in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares in the last quarter. Truist Financial Corp boosted its stake in shares of HealthEquity by 7.0% in the second quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after acquiring an additional 188 shares during the last quarter. Finally, Nicolet Advisory Services LLC increased its position in shares of HealthEquity by 5.8% during the third quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after purchasing an additional 233 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 1.8 %

HQY opened at $114.51 on Thursday. The business’s 50 day moving average price is $101.63 and its 200 day moving average price is $90.37. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $9.92 billion, a PE ratio of 105.06, a P/E/G ratio of 1.61 and a beta of 0.55. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $114.69.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the business posted $0.40 earnings per share. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insiders Place Their Bets

In other news, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,000 shares of company stock valued at $3,895,788 over the last 90 days. 2.20% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on HQY shares. BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Royal Bank of Canada raised their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Bank of America boosted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Barrington Research increased their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. Finally, The Goldman Sachs Group initiated coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.